CYFRA21-1 might be predictive marker in advanced NSCLC

March 15, 2012

Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.

As part of a study performed by the Cancer and Leukemia Group B in advanced lung cancer, serum CYFRA levels were measured at baseline and after the first cycle of treatment. According to the study, "higher baseline CYFRA concentrations portend worse overall and failure free survival. Additionally, this trial confirmed the significance of the cut point of a 27 percent reduction in log CYFRA after chemotherapy is of value in determining benefit from treatment."

Researchers warn that further studies are needed, but "if confirmed, this would provide a simple and inexpensive approach to assessment of response to treatment."

The lead author of this work is IALSC member Dr. Martin Edelman. IASLC member co-authors include Dr. Everett Vokes and Dr. Robert Kratzke.

Explore further: Advanced lung cancer patients see improved, progression-free survival

Related Stories

Recommended for you

Oxygen can impair cancer immunotherapy in mice

August 25, 2016

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer ...

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells - special cells that divide to repair and generate tissues - might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.